It’s an exciting time in this challenging, yet ever-evolving, field

Innovation in pharma is playing a key role in transforming science, healthcare and even the wider society. From the chance discovery of penicillin to the Human Genome Project – one of the world’s largest collaborative scientific endeavours – we have seen the eradication of devastating diseases, improvements in patient outcomes and an exponential increase in global life expectancy.

Despite these achievements, there is always significant need for present-day pharma to boldly step forward and embrace tomorrow’s technologies. Global society faces a plethora of growing pressures that make the future of healthcare uncertain. An ageing population, the complexity of therapeutic targets and the astronomical expense and high attrition rates in drug commercialisation are but a few of the challenges impacting healthcare.

To combat these concerns, organisations working across the pharma spectrum are peering into the future to deliver tangible changes to present-day healthcare. However, no crystal ball is needed. Significant technological advances, ingenious thinking and multidisciplinary collaboration are helping deliver tomorrow’s solutions today.

The sixth digital supplement developed by Notch Communications and Chemistry World highlights just this. Our latest issue details how innovative and future-facing organisations are solving some of the most significant challenges across the pharmaceutical and healthcare pipeline.

From the inaugural Tech for Health supplement to the most recent Voices in Chemistry collection, our digital issues showcase impactful and exciting research undertaken around the world. Tomorrow’s technologies in pharma and healthcare exemplify just why it is so exciting to be working within this dynamic field.

Among these exciting articles is one from leading specialty measurement company Waters Corporation outlining how ion mobility spectrometry is allowing researchers to deep dive into analysis of complex therapeutic targets at levels that were previously impossible. Nanoform explores how nanonization and artificial intelligence algorithms can be used to tackle the ageing population crisis. Our partners at CPI discuss how collaborations between multiple stakeholders can transcend global competition and unite key organisations to solve pharma’s most complex problems.

In this issue we’ve explored how the pharmaceutical and healthcare industries are realising the future of pharma through transformative and novel approaches to complex problems. For the next supplement, we’re broadening our horizons to explore innovations within the chemistry of our everyday life; showcasing how ordinary products and services are delivered through extraordinary technology. If your research group or organisation has a story that you think will be a good fit then please get in touch.